Showing results (71-80 of 282) with videos related to

Sort By:
Pageof 29
Breast Cancer : Basic and Clinical Research|December 14, 2020
miRNA Expression Analysis: Cell Lines HCC1500 and HCC1937 as Models for Breast Cancer in Young Women and the miR-23a as a Poor Prognostic BiomarkerSara S Oltra, Maria Peña-Chilet, Maria T Martinez, et al.
Cancer Chemotherapy and Pharmacology|August 2, 2019
Sunitinib rechallenge in advanced renal cell carcinoma: outcomes of a multicenter retrospective studyJavier Munárriz, Gaspar Reynés, Luisa Sánchez-Lorenzo, et al.
Cancer Biomarkers : Section a of Disease Markers|May 25, 2007
Polymorphisms in TRAIL receptor genes and risk of breast cancer in Spanish womenJosé I Martinez-Ferrandis, Raquel Rodríguez-López, Roger L Milne, et al.
Experimental Hematology & Oncology|November 22, 2014
Activity of dalotuzumab, a selective anti-IGF1R antibody, in combination with erlotinib in unselected patients with Non-small-cell lung cancer: a phase I/II randomized trialTeresa Moran, Enriqueta Felip, Vicki Keedy, et al.
Breast Cancer Research and Treatment|December 7, 2007
Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer familySarai Palanca Suela, Eva Esteban Cardeñosa, Eva Barragán González, et al.
The Oncologist|February 3, 2019
Neoadjuvant Management of Early Breast Cancer: A Clinical and Investigational Position StatementRamon Colomer, Cristina Saura, Pedro Sánchez-Rovira, et al.
Critical Reviews in Oncology/Hematology|August 31, 2015
Treatment of HER2 positive advanced breast cancer with T-DM1: A review of the literatureMaría Teresa Martínez, José Alejandro Pérez-Fidalgo, Paloma Martín-Martorell, et al.
Medicina Clinica|February 19, 2008
[BRCA1 and BRCA2 mutations in families studied in the program of genetic counselling in cancer of the Valencian community (Spain)]Eva Esteban Cardeñosa, Pascual Bolufer Gilabert, Sarai Palanca Suela, et al.
ACS Sensors|February 18, 2021
Nanoporous Anodic Alumina-Based Sensor for miR-99a-5p Detection as an Effective Early Breast Cancer Diagnostic ToolIris Garrido-Cano, Luis Pla, Sara Santiago-Felipe, et al.
Breast Cancer Research : BCR|October 30, 2012
Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancerFunda Meric-Bernstam, Huiqin Chen, Argun Akcakanat, et al.
Pageof 29